Farris Maryanne Maunsell serves as Executive at HAEMONETICS CORP, where they oversee executive responsibilities. Since joining the company, Farris Maryanne Maunsell has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 17, 2024 involved receiving (via award) 587 shares valued at $0.
Farris Maryanne Maunsell currently holds 1,144 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Farris Maryanne Maunsell has been a net neutral trader of HAE stock. They have purchased $0 and sold $0 worth of shares.
Farris Maryanne Maunsell's most recent insider trade was on May 17, 2024, when they sold 587 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $96.49 |
| Discretionary |
| May 15, 2023 | HAE | $0 | Award | 630 | $N/A | Discretionary |